Note D - Stock Based Compensation | 9 Months Ended |
Sep. 30, 2014 |
Disclosure Text Block Supplement [Abstract] | ' |
Compensation and Employee Benefit Plans [Text Block] | ' |
NOTE D: STOCK BASED COMPENSATION |
|
The Company maintains a stock option plan under which incentive stock options and nonqualified stock options may be granted. On March 2, 2006, the Company’s Board of Director’s (the “Board”) adopted, and shareholders later approved, the 2006 Stock Option Plan (the “2006 Plan”). Under the 2006 Plan, 750,000 shares were reserved for the issuance of stock options to directors, officers, key employees, and others. The option exercise price under the 2006 Plan is the fair market value of the stock on the date the option is granted. The fair market value is determined by the closing price of the Company’s common stock, on its primary exchange, on the same date that the option is granted. On March 13, 2014, the Company’s Board of Directors adopted and on May 29, 2014, our shareholders approved, the 2014 Amended and Restated Stock Option and Incentive Plan (the “2014 Plan”) which replaced the 2006 Plan. The shares which remained reserved under the 2006 Plan were transferred to the 2014 Plan and are reserved for the issuance of stock awards to directors, officers, key employees, and others. Stock option exercise price under the 2014 Plan is the fair market value of the stock on the date the option is granted. The restricted stock purchase price under the 2014 Plan shall not be less than 85% of the fair market value of the Company’s common stock on the date the award is made. The fair market value is determined by the average of the highest and lowest sales prices for a share of the Company’s common stock, on its primary exchange, on the same date that the option or award is granted. |
|
Outstanding nonqualified stock options at September 30, 2014, must be exercised within either five or ten years from the date of grant. |
|
During the first nine months of 2014, 3,024 shares of common stock were granted to non-employee directors under the 2014 Plan. This stock award has a grant date fair value of $19.88 per share, based on the closing price of the Company’s stock on the date of grant and vests immediately. |
|
The total grant date fair value of stock and stock options vested during the first nine months of 2014 was approximately $148,000. Total pre-tax stock-based compensation expense, recognized in Salaries, wages and benefits during the third quarter of 2014 was approximately $30,000. Total pre-tax stock-based compensation expense, recognized in Salaries, wages and benefits during the first nine months of 2014 was approximately $146,000 and includes approximately $60,000 recognized as a result of the grant of 504 shares to each non-employee director during the first quarter of 2014. The recognition of stock-based compensation expense did not have a recognizable impact on diluted or basic earnings per share reported for the third quarter ended September 30, 2014 but did decrease diluted and basic earnings per common share by approximately $0.02 during the nine months ended September 30, 2014. As of September 30, 2014, the Company had stock-based compensation plans with total unvested stock-based compensation expense of approximately $260,000 which is being amortized on a straight-line basis over the remaining vesting period. As a result, the Company expects to recognize approximately $30,000 in additional compensation expense related to unvested option awards during the remainder of 2014 and to recognize approximately $116,000, $86,000, and $28,000 in additional compensation expense related to unvested option awards during the years 2015, 2016, and 2017, respectively. |
|
The total grant date fair value of options vested during the first nine months of 2013 was approximately $180,000. Total pre-tax stock-based compensation expense, recognized in Salaries, wages and benefits during the third quarter of 2013 was approximately $39,000. Total pre-tax stock-based compensation expense, recognized in Salaries, wages and benefits during the first nine months of 2013 was approximately $315,000 and includes approximately $180,000 recognized as a result of the increased annual grant of 5,000 shares to each non-employee director during the first nine months of 2013. The recognition of stock-based compensation expense did not have a recognizable impact on diluted or basic earnings per share reported for the third quarter ended September 30, 2013 but did decrease diluted and basic earnings per common share by approximately $0.02 and $0.03, respectively, during the nine months ended September 30, 2013. |
|
The weighted average grant date fair value of options granted during the first nine months of 2013 was $5.13 per share. There were no options granted during the first nine months of 2014. |
|
The fair value of the Company’s employee stock options was estimated at the date of grant using a Black-Scholes-Merton (“BSM”) option-pricing model using the following assumptions: |
|
| Nine Months Ended | | | | | | | | | | | | | | | |
| 30-Sep-13 | | | | | | | | | | | | | | | |
Dividend yield | 0% | | | | | | | | | | | | | | | |
Volatility | 62.69% | | | | | | | | | | | | | | | |
Risk-free rate | 0.61% | | | | | | | | | | | | | | | |
Expected life (years) | 4.3 | | | | | | | | | | | | | | | |
Fair value of options | $5.13 | | | | | | | | | | | | | | | |
|
The Company does not anticipate paying any cash dividends in the foreseeable future. The estimated volatility is based on the historical volatility of our stock. The risk free rate for the periods within the expected life of the option is based on the U.S. Treasury yield curve in effect at the time of grant. The expected life of the options was calculated based on the historical exercise behavior. |
|
Information related to stock option activity for the nine months ended September 30, 2014 is as follows: |
|
| | Shares Under Options | | | Weighted-Average Exercise Price | | | Weighted- Average Remaining Contractual Term | | | Aggregate Intrinsic Value* | |
| | | | | | (per share) | | | (in years) | | | | | |
Outstanding-beginning of year | | | 164,098 | | | $ | 10.99 | | | | | | | | | |
Granted | | | - | | | | - | | | | | | | | | |
Exercised | | | (77,308 | ) | | | 10.88 | | | | | | | | | |
Cancelled/forfeited/expired | | | (42 | ) | | | 11.22 | | | | | | | | | |
Outstanding at September 30, 2014 | | | 86,748 | | | $ | 11.09 | | | | 5.5 | | | $ | 2,182,370 | |
| | | | | | | | | | | | | | | | |
Exercisable at September 30, 2014 | | | 33,139 | | | $ | 11.29 | | | | 2.6 | | | $ | 827,289 | |
|
___________________________ | | | | | | | | | | | | | | | | |
* The intrinsic value of a stock option is the amount by which the market value of the underlying stock exceeds the exercise price of the option. The per share market value of our common stock, as determined by the closing price on September 30, 2014, was $36.25. | | | | | | | | | | | | | | | | |
|
A summary of the status of the Company’s nonvested options and restricted stock as of September 30, 2014 and changes during the nine months ended September 30, 2014, is presented below: |
|
Stock Options: |
|
| | Number of Options | | | Weighted- Average Grant Date Fair Value | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Nonvested at January 1, 2014 | | | 68,039 | | | $ | 6.11 | | | | | | | | | |
Granted | | | - | | | | - | | | | | | | | | |
Canceled/forfeited/expired | | | (25 | ) | | | 6.34 | | | | | | | | | |
Vested | | | (14,405 | ) | | | 6.07 | | | | | | | | | |
Nonvested at September 30, 2014 | | | 53,609 | | | $ | 6.12 | | | | | | | | | |
|
Restricted Stock: |
|
| | Number of Options | | | Weighted- Average Grant Date Fair Value | | | | | | | | | |
| | | | | | | | | | | | | | | | |
Nonvested at January 1, 2014 | | | 9,500 | | | $ | 18.17 | | | | | | | | | |
Granted | | | - | | | | - | | | | | | | | | |
Canceled/forfeited/expired | | | (9,500 | ) | | | 18.17 | | | | | | | | | |
Vested | | | - | | | | - | | | | | | | | | |
Nonvested at September 30, 2014 | | | - | | | $ | - | | | | | | | | | |
|
The number, weighted average exercise price and weighted average remaining contractual life of options outstanding as of September 30, 2014 and the number and weighted average exercise price of options exercisable as of September 30, 2014 are as follows: |
|
Exercise Price | | Shares Under | | Weighted-Average | | Shares Under | | | | | | | | | | |
Outstanding Options | Remaining Contractual | Exercisable Options | | | | | | | | | | |
| Term | | | | | | | | | | | |
| | | | (in years) | | | | | | | | | | | | |
$10.44 | | 15,000 | | 3.4 | | 15,000 | | | | | | | | | | |
$10.90 | | 6,000 | | 2.7 | | 6,000 | | | | | | | | | | |
$10.90 | | 41,400 | | 7.7 | | - | | | | | | | | | | |
$11.22 | | 12,348 | | 6.2 | | 139 | | | | | | | | | | |
$11.54 | | 4,000 | | 2.4 | | 4,000 | | | | | | | | | | |
$11.75 | | 4,000 | | 1.4 | | 4,000 | | | | | | | | | | |
$14.32 | | 4,000 | | 0.4 | | 4,000 | | | | | | | | | | |
| | 86,748 | | 5.5 | | 33,139 | | | | | | | | | | |
|
Cash received from option exercises totaled approximately $841,000 and $19,000 during the nine months ended September 30, 2014 and September 30, 2013, respectively. The Company issues new shares upon option exercise. |